Zobrazeno 1 - 10 of 781 pro vyhledávání: '"de Cristofaro T."'
1
Akademický článek
ICOSLG Is Associated with Anti-PD-1 and Concomitant Antihistamine Treatment Response in Advanced Melanoma.
Autor: Mallardo D; Melanoma, Cancer Immunotherapy and Development Therapeutics Unit, Istituto Nazionale Tumori IRCCS 'Fondazione G. Pascale', Via Mariano Semmola, 53, 80131 Naples, Italy., Fordellone M; Medical Statistics Unit, Universitiy of Campania 'Luigi Vanvitelli', 81100 Naples, Italy., Ottaviano M; Melanoma, Cancer Immunotherapy and Development Therapeutics Unit, Istituto Nazionale Tumori IRCCS 'Fondazione G. Pascale', Via Mariano Semmola, 53, 80131 Naples, Italy., Marano G; Melanoma, Cancer Immunotherapy and Development Therapeutics Unit, Istituto Nazionale Tumori IRCCS 'Fondazione G. Pascale', Via Mariano Semmola, 53, 80131 Naples, Italy., Vitale MG; Melanoma, Cancer Immunotherapy and Development Therapeutics Unit, Istituto Nazionale Tumori IRCCS 'Fondazione G. Pascale', Via Mariano Semmola, 53, 80131 Naples, Italy., Mallardo M; Melanoma, Cancer Immunotherapy and Development Therapeutics Unit, Istituto Nazionale Tumori IRCCS 'Fondazione G. Pascale', Via Mariano Semmola, 53, 80131 Naples, Italy., Capasso M; Melanoma, Cancer Immunotherapy and Development Therapeutics Unit, Istituto Nazionale Tumori IRCCS 'Fondazione G. Pascale', Via Mariano Semmola, 53, 80131 Naples, Italy., De Cristofaro T; Melanoma, Cancer Immunotherapy and Development Therapeutics Unit, Istituto Nazionale Tumori IRCCS 'Fondazione G. Pascale', Via Mariano Semmola, 53, 80131 Naples, Italy., Capone M; Melanoma, Cancer Immunotherapy and Development Therapeutics Unit, Istituto Nazionale Tumori IRCCS 'Fondazione G. Pascale', Via Mariano Semmola, 53, 80131 Naples, Italy., Meinardi T; Melanoma, Cancer Immunotherapy and Development Therapeutics Unit, Istituto Nazionale Tumori IRCCS 'Fondazione G. Pascale', Via Mariano Semmola, 53, 80131 Naples, Italy., Paone M; Melanoma, Cancer Immunotherapy and Development Therapeutics Unit, Istituto Nazionale Tumori IRCCS 'Fondazione G. Pascale', Via Mariano Semmola, 53, 80131 Naples, Italy., Sabatelli P; Melanoma, Cancer Immunotherapy and Development Therapeutics Unit, Istituto Nazionale Tumori IRCCS 'Fondazione G. Pascale', Via Mariano Semmola, 53, 80131 Naples, Italy., De Filippi R; Department of Clinical Medicine and Surgery, University of Naples Federico II, 80138 Naples, Italy., Cesano A; ESSA Pharma, South San Francisco, CA 94080, USA., Cavalcanti E; Division of Laboratory Medicine, Istituto Nazionale Tumori IRCCS 'Fondazione G. Pascale', 80131 Naples, Italy., Caracò C; Division of Surgery of Melanoma and Skin Cancer, Istituto Nazionale Tumori IRCCS 'Fondazione G. Pascale', 80131 Naples, Italy., Warren S; ESSA Pharma, South San Francisco, CA 94080, USA., Budillon A; Istituto Nazionale Tumori IRCCS 'Fondazione G. Pascale', 80131 Naples, Italy., Simeone E; Melanoma, Cancer Immunotherapy and Development Therapeutics Unit, Istituto Nazionale Tumori IRCCS 'Fondazione G. Pascale', Via Mariano Semmola, 53, 80131 Naples, Italy., Ascierto PA; Melanoma, Cancer Immunotherapy and Development Therapeutics Unit, Istituto Nazionale Tumori IRCCS 'Fondazione G. Pascale', Via Mariano Semmola, 53, 80131 Naples, Italy.
Publikováno v: International journal of molecular sciences [Int J Mol Sci] 2024 Nov 19; Vol. 25 (22). Date of Electronic Publication: 2024 Nov 19.
Zobrazit plný text záznamu
2
Akademický článek
PAX8, an Emerging Player in Ovarian Cancer.
Autor: Gokulnath P; Institute of Experimental Endocrinology and Oncology 'G. Salvatore' (IEOS) - CNR, National Research Council, Naples, Italy., Soriano AA; Institute of Experimental Endocrinology and Oncology 'G. Salvatore' (IEOS) - CNR, National Research Council, Naples, Italy., de Cristofaro T; Institute of Experimental Endocrinology and Oncology 'G. Salvatore' (IEOS) - CNR, National Research Council, Naples, Italy., Di Palma T; Institute of Experimental Endocrinology and Oncology 'G. Salvatore' (IEOS) - CNR, National Research Council, Naples, Italy., Zannini M; Institute of Experimental Endocrinology and Oncology 'G. Salvatore' (IEOS) - CNR, National Research Council, Naples, Italy. s.zannini@ieos.cnr.it.
Publikováno v: Advances in experimental medicine and biology [Adv Exp Med Biol] 2021; Vol. 1330, pp. 95-112.
Zobrazit plný text záznamu
3
Akademický článek
Nivolumab serum concentration in metastatic melanoma patients could be related to outcome and enhanced immune activity: a gene profiling retrospective analysis.
Autor: Mallardo D; Instituto Nazionale Tumori IRCCS Fondazione Pascale, Napoli, Italy., Giannarelli D; Instituto Nazionale Tumori IRCCS Fondazione Pascale, Napoli, Italy., Vitale MG; Instituto Nazionale Tumori IRCCS Fondazione Pascale, Napoli, Italy., Galati D; Instituto Nazionale Tumori IRCCS Fondazione Pascale, Napoli, Italy., Trillò G; Instituto Nazionale Tumori IRCCS Fondazione Pascale, Napoli, Italy., Esposito A; Instituto Nazionale Tumori IRCCS Fondazione Pascale, Napoli, Italy., Isgrò MA; Instituto Nazionale Tumori IRCCS Fondazione Pascale, Napoli, Italy., D'Angelo G; Instituto Nazionale Tumori IRCCS Fondazione Pascale, Napoli, Italy., Festino L; Instituto Nazionale Tumori IRCCS Fondazione Pascale, Napoli, Italy., Vanella V; Instituto Nazionale Tumori IRCCS Fondazione Pascale, Napoli, Italy., Trojaniello C; Instituto Nazionale Tumori IRCCS Fondazione Pascale, Napoli, Italy., White A; NanoString Technologies Inc, Seattle, Washington, USA., De Cristofaro T; Instituto Nazionale Tumori IRCCS Fondazione Pascale, Napoli, Italy., Bailey M; NanoString Technologies Inc, Seattle, Washington, USA., Pignata S; Instituto Nazionale Tumori IRCCS Fondazione Pascale, Napoli, Italy., Caracò C; Instituto Nazionale Tumori IRCCS Fondazione Pascale, Napoli, Italy., Petrillo A; Instituto Nazionale Tumori IRCCS Fondazione Pascale, Napoli, Italy., Muto P; Instituto Nazionale Tumori IRCCS Fondazione Pascale, Napoli, Italy., Maiolino P; Instituto Nazionale Tumori IRCCS Fondazione Pascale, Napoli, Italy., Budillon A; Instituto Nazionale Tumori IRCCS Fondazione Pascale, Napoli, Italy., Warren S; NanoString Technologies Inc, Seattle, Washington, USA., Cavalcanti E; Instituto Nazionale Tumori IRCCS Fondazione Pascale, Napoli, Italy., Ascierto PA; Instituto Nazionale Tumori IRCCS Fondazione Pascale, Napoli, Italy paolo.ascierto@gmail.com.
Publikováno v: Journal for immunotherapy of cancer [J Immunother Cancer] 2022 Nov; Vol. 10 (11).
Zobrazit plný text záznamu
4
Akademický článek
Concomitant medication of cetirizine in advanced melanoma could enhance anti-PD-1 efficacy by promoting M1 macrophages polarization.
Autor: Mallardo D; Melanoma, Cancer Immunotherapy and Development Therapeutics Unit, Istituto Nazionale Tumori - IRCCS - Fondazione 'G. Pascale', Naples, Italy., Simeone E; Melanoma, Cancer Immunotherapy and Development Therapeutics Unit, Istituto Nazionale Tumori - IRCCS - Fondazione 'G. Pascale', Naples, Italy., Vanella V; Melanoma, Cancer Immunotherapy and Development Therapeutics Unit, Istituto Nazionale Tumori - IRCCS - Fondazione 'G. Pascale', Naples, Italy., Vitale MG; Melanoma, Cancer Immunotherapy and Development Therapeutics Unit, Istituto Nazionale Tumori - IRCCS - Fondazione 'G. Pascale', Naples, Italy., Palla M; Melanoma, Cancer Immunotherapy and Development Therapeutics Unit, Istituto Nazionale Tumori - IRCCS - Fondazione 'G. Pascale', Naples, Italy., Scarpato L; Melanoma, Cancer Immunotherapy and Development Therapeutics Unit, Istituto Nazionale Tumori - IRCCS - Fondazione 'G. Pascale', Naples, Italy., Paone M; Melanoma, Cancer Immunotherapy and Development Therapeutics Unit, Istituto Nazionale Tumori - IRCCS - Fondazione 'G. Pascale', Naples, Italy., De Cristofaro T; Melanoma, Cancer Immunotherapy and Development Therapeutics Unit, Istituto Nazionale Tumori - IRCCS - Fondazione 'G. Pascale', Naples, Italy., Borzillo V; Radiation Oncology Unit, Istituto Nazionale Tumori - IRCCS -Fondazione 'G. Pascale', Naples, Italy., Cortellini A; Department of Surgery & Cancer, Imperial College London, Hammersmith Hospital, Du Cane Road, London, W120HS, UK., Sparano F; Melanoma, Cancer Immunotherapy and Development Therapeutics Unit, Istituto Nazionale Tumori - IRCCS - Fondazione 'G. Pascale', Naples, Italy., Pignata S; Department of Urology and Gynecology, Istituto Nazionale Tumori - IRCCS -Fondazione 'G. Pascale', Naples, Italy., Fiore F; Interventional Radiology Unit, Istituto Nazionale Tumori - IRCCS -Fondazione 'G. Pascale', Naples, Italy., Caracò C; Division of Surgery of Melanoma and Skin Cancer, Istituto Nazionale Tumori - IRCCS - Fondazione 'G. Pascale', Naples, Italy., Maiolino P; Hospital Pharmacy, Istituto Nazionale Tumori - IRCCS - Fondazione 'G. Pascale', Naples, Italy., Petrillo A; Radiology Division, Istituto Nazionale Tumori - IRCCS - Fondazione 'G. Pascale', Naples, Italy., Cavalcanti E; Division of Laboratory Medicine, Istituto Nazionale Tumori - IRCCS -Fondazione 'G. Pascale', Naples, Italy., Lastoria S; Nuclear Medicine Unit, Istituto Nazionale Tumori - IRCCS - Fondazione 'G. Pascale', Naples, Italy., Muto P; Radiation Oncology Unit, Istituto Nazionale Tumori - IRCCS -Fondazione 'G. Pascale', Naples, Italy., Budillon A; Experimental Pharmacology Unit, Istituto Nazionale Tumori - IRCCS - Fondazione 'G. Pascale', Naples, Italy., Warren S; NanoString Technologies, Seattle, WA, USA., Ascierto PA; Melanoma, Cancer Immunotherapy and Development Therapeutics Unit, Istituto Nazionale Tumori - IRCCS - Fondazione 'G. Pascale', Naples, Italy. p.ascierto@istitutotumori.na.it.
Publikováno v: Journal of translational medicine [J Transl Med] 2022 Sep 30; Vol. 20 (1), pp. 436. Date of Electronic Publication: 2022 Sep 30.
Zobrazit plný text záznamu
5
Akademický článek
Variable levels of spike and ORF1ab RNA in post-mortem lung samples of SARS-CoV-2-positive subjects: comparison between ISH and RT-PCR.
Autor: Zito Marino F; Pathology Unit, Department of Mental and Physical Health and Preventive Medicine, Università degli Studi della Campania 'L Vanvitelli', via Luciano Armanni 5, 80138, Naples, Italy., De Cristofaro T; IEOS - Institute of Experimental Endocrinology and Oncology 'G. Salvatore', National Research Council, via S. Pansini 5, 80131, Naples, Italy.; BioMol Laboratories srl, Corso San Giovanni 849, 80146, Naples, Italy., Varriale M; BioMol Laboratories srl, Corso San Giovanni 849, 80146, Naples, Italy., Zannini G; Pathology Unit, Department of Mental and Physical Health and Preventive Medicine, Università degli Studi della Campania 'L Vanvitelli', via Luciano Armanni 5, 80138, Naples, Italy., Ronchi A; Pathology Unit, Department of Mental and Physical Health and Preventive Medicine, Università degli Studi della Campania 'L Vanvitelli', via Luciano Armanni 5, 80138, Naples, Italy., La Mantia E; Pathology Unit, Department of Mental and Physical Health and Preventive Medicine, Università degli Studi della Campania 'L Vanvitelli', via Luciano Armanni 5, 80138, Naples, Italy., Campobasso CP; Department of Experimental Medicine, University of Campania, Luigi Vanvitelli, Naples, Italy., De Micco F; Department of Experimental Medicine, University of Campania, Luigi Vanvitelli, Naples, Italy., Mascolo P; Department of Experimental Medicine, University of Campania, Luigi Vanvitelli, Naples, Italy., Municinò M; Forensic Medicine Unit, 'S. Giuliano' Hospital, Giugliano in Campania, Italy., Municinò E; Forensic Medicine Unit, 'S. Giuliano' Hospital, Giugliano in Campania, Italy., Vestini F; Forensic Medicine Unit, 'S. Giuliano' Hospital, Giugliano in Campania, Italy., Pinto O; Forensic Medicine Unit, 'S. Giuliano' Hospital, Giugliano in Campania, Italy., Moccia M; Forensic Medicine Unit, 'S. Giuliano' Hospital, Giugliano in Campania, Italy., De Stefano N; Pathology Unit, 'San Giuseppe Moscati' Hospital, Avellino, Italy., Nappi O; Istituto Diagnostico 'Varelli', Naples, Italy., Sementa C; Forensic Medicine Unit, AORN 'San Giuseppe Moscati, Contrada Amoretta, 83100, Avellino, Italy., Zotti G; Forensic Medicine Unit, ASL Salerno, Salerno, Italy., Pianese L; Forensic Medicine Unit, ASL Avellino, Avellino, Italy., Giordano C; Forensic Medicine Unit, UOPC ASL NA3sud, Naples, Italy., Franco R; Pathology Unit, Department of Mental and Physical Health and Preventive Medicine, Università degli Studi della Campania 'L Vanvitelli', via Luciano Armanni 5, 80138, Naples, Italy. renato.franco@unicampania.it.
Publikováno v: Virchows Archiv : an international journal of pathology [Virchows Arch] 2022 Mar; Vol. 480 (3), pp. 597-607. Date of Electronic Publication: 2022 Feb 01.
Zobrazit plný text záznamu
6
Akademický článek
Loss of Detection of sgN Precedes Viral Abridged Replication in COVID-19-Affected Patients-A Target for SARS-CoV-2 Propagation.
Autor: Ferrucci V; CEINGE Biotecnologie Avanzate, 80145 Naples, Italy.; Dipartimento di Medicina Molecolare e Biotecnologie Mediche (DMMBM), University of Naples Federico II, 80131 Naples, Italy., de Antonellis P; CEINGE Biotecnologie Avanzate, 80145 Naples, Italy.; Dipartimento di Medicina Molecolare e Biotecnologie Mediche (DMMBM), University of Naples Federico II, 80131 Naples, Italy., Quarantelli F; Dipartimento di Medicina Molecolare e Biotecnologie Mediche (DMMBM), University of Naples Federico II, 80131 Naples, Italy., Asadzadeh F; CEINGE Biotecnologie Avanzate, 80145 Naples, Italy.; Dipartimento di Medicina Molecolare e Biotecnologie Mediche (DMMBM), University of Naples Federico II, 80131 Naples, Italy., Bibbò F; CEINGE Biotecnologie Avanzate, 80145 Naples, Italy.; Dipartimento di Medicina Molecolare e Biotecnologie Mediche (DMMBM), University of Naples Federico II, 80131 Naples, Italy., Siciliano R; CEINGE Biotecnologie Avanzate, 80145 Naples, Italy., Sorice C; CEINGE Biotecnologie Avanzate, 80145 Naples, Italy.; Dipartimento di Medicina Molecolare e Biotecnologie Mediche (DMMBM), University of Naples Federico II, 80131 Naples, Italy., Pisano I; CEINGE Biotecnologie Avanzate, 80145 Naples, Italy., Izzo B; CEINGE Biotecnologie Avanzate, 80145 Naples, Italy.; Dipartimento di Medicina Molecolare e Biotecnologie Mediche (DMMBM), University of Naples Federico II, 80131 Naples, Italy., Di Domenico C; CEINGE Biotecnologie Avanzate, 80145 Naples, Italy., Boccia A; CEINGE Biotecnologie Avanzate, 80145 Naples, Italy., Vargas M; Department of Neurosciences, Reproductive Sciences and Odontostomatology, University of Naples Federico II, 80131 Naples, Italy., Pierri B; Istituto Zooprofilattico Sperimentale del Mezzogiorno, 80055 Naples, Italy., Viscardi M; Istituto Zooprofilattico Sperimentale del Mezzogiorno, 80055 Naples, Italy., Brandi S; Istituto Zooprofilattico Sperimentale del Mezzogiorno, 80055 Naples, Italy., Fusco G; Istituto Zooprofilattico Sperimentale del Mezzogiorno, 80055 Naples, Italy., Cerino P; Istituto Zooprofilattico Sperimentale del Mezzogiorno, 80055 Naples, Italy., De Pietro L; U.O.C. Pneumologia, Ospedale Boscotrecase-Asl Napoli3 Sud, 80042 Naples, Italy., Furfaro C; Dipartimento di Medicina di Laboratorio e Anatomia Patologica, Nola Hospital, Asl Napoli 3 Sud, 80035 Naples, Italy., Napolitano LA; Dipartimento di Medicina di Laboratorio e Anatomia Patologica, Nola Hospital, Asl Napoli 3 Sud, 80035 Naples, Italy., Paolella G; CEINGE Biotecnologie Avanzate, 80145 Naples, Italy.; Dipartimento di Medicina Molecolare e Biotecnologie Mediche (DMMBM), University of Naples Federico II, 80131 Naples, Italy., Festa L; Unità Speciale di Continuità Assistenziale (USCA), Asl Benevento, 82100 Benevento, Italy.; Dipartimento di Medicina Clinica e Chirurgia, University of Naples Federico II, 80131 Naples, Italy., Marzinotto S; Dipartimento di Medicina di Laboratorio, Università degli Studi di Udine, 33100 Udine, Italy., Conte MC; Unità Speciale di Continuità Assistenziale (USCA), Asl Benevento, 82100 Benevento, Italy., Gentile I; Dipartimento di Medicina Clinica e Chirurgia, University of Naples Federico II, 80131 Naples, Italy., Servillo G; Department of Neurosciences, Reproductive Sciences and Odontostomatology, University of Naples Federico II, 80131 Naples, Italy., Curcio F; Dipartimento di Medicina di Laboratorio, Università degli Studi di Udine, 33100 Udine, Italy., de Cristofaro T; IEOS-Institute of Experimental Endocrinology and Oncology G. Salvatore, National Research Council, 80131 Naples, Italy.; BioMol Laboratories srl, 80146 Naples, Italy., Broccolo F; Laboratory of Molecular Microbiology and Virology, School of Medicine, University of Milano-Bicocca, 20900 Monza, Italy., Capoluongo E; CEINGE Biotecnologie Avanzate, 80145 Naples, Italy.; Dipartimento di Medicina Molecolare e Biotecnologie Mediche (DMMBM), University of Naples Federico II, 80131 Naples, Italy.; DAI Medicina di Laboratorio e Trasfusionale, University of Naples Federico II, 80131 Naples, Italy., Zollo M; CEINGE Biotecnologie Avanzate, 80145 Naples, Italy.; Dipartimento di Medicina Molecolare e Biotecnologie Mediche (DMMBM), University of Naples Federico II, 80131 Naples, Italy.; DAI Medicina di Laboratorio e Trasfusionale, University of Naples Federico II, 80131 Naples, Italy.
Publikováno v: International journal of molecular sciences [Int J Mol Sci] 2022 Feb 09; Vol. 23 (4). Date of Electronic Publication: 2022 Feb 09.
Zobrazit plný text záznamu
7
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
8
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
9
Akademický článek
Subtype-specific analysis of gene co-expression networks and immune cell profiling reveals high grade serous ovarian cancer subtype linkage to variable immune microenvironment.
Autor: Carey, Kaylin M.1 (AUTHOR), Young, Corey D.2 (AUTHOR), Clark, Alexis J.1 (AUTHOR), Dammer, Eric B.3,4 (AUTHOR), Singh, Rajesh1 (AUTHOR), Lillard Jr., James W.1 (AUTHOR) jlillard@msm.edu
Publikováno v: Journal of Ovarian Research. 12/3/2024, Vol. 17 Issue 1, p1-18. 18p.
Zobrazit plný text záznamu
10
Akademický článek
Ten Hypermethylated lncRNA Genes Are Specifically Involved in the Initiation, Progression, and Lymphatic and Peritoneal Metastasis of Epithelial Ovarian Cancer.
Autor: Braga, Eleonora A.1 (AUTHOR) eleonora10_45@mail.ru, Burdennyy, Alexey M.1 (AUTHOR) danilamihailovich@mail.ru, Uroshlev, Leonid A.2 (AUTHOR) leoniduroshlev@gmail.com, Zaichenko, Danila M.1 (AUTHOR) p.lenyxa@yandex.ru, Filippova, Elena A.1 (AUTHOR) sveta_sergeevna349@mail.ru, Lukina, Svetlana S.1 (AUTHOR) zolly_sten@mail.ru, Pronina, Irina V.1 (AUTHOR) astafevayr@gmail.com, Astafeva, Iana R.1 (AUTHOR) loginov7w@gmail.com, Fridman, Marina V.2 (AUTHOR) marina-free@mail.ru, Kazubskaya, Tatiana P.3 (AUTHOR) oncogen5@ronc.ru, Loginov, Vitaly I.1 (AUTHOR) alexey.moscovtsev@gmail.com, Dmitriev, Alexey A.4 (AUTHOR) alex_245@mail.ru, Moskovtsev, Aleksey A.1,3,5 (AUTHOR) kne3108@gmail.com, Kushlinskii, Nikolay E.3 (AUTHOR)
Publikováno v: International Journal of Molecular Sciences. Nov2024, Vol. 25 Issue 21, p11843. 32p.
Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání

Omezení vyhledávání
Plný text Recenzováno Digitální knihovna AV ČR
Zdroje